Nuclear lamina damage in AD was originally described in a model of tauopathy in Drosophila, in which genetic inhibition of thioredoxin reductase‐1 (TrxR1) or superoxide dismutase resulted in hyperphosphorylation of Tau and changes in chromatin density. Here, MAPT is linked to Alzheimer disease.